March 28, 2023
Santen Pharmaceutical said on March 27 that it has filed a new drug application for an ophthalmic cream formulation of epinastine for the treatment of allergic conjunctivitis. The ophthalmic cream, which carries the development code STN1011402, contains epinastine 0.5%, a...read more